These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9617589)

  • 21. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.
    Duehrkop C; Rieben R
    Biochem Pharmacol; 2014 Mar; 88(1):12-22. PubMed ID: 24384116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic inhibition of the early phase of complement activation.
    Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
    Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The complement system: an old story or target of new therapeutic approaches?].
    Heller A; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Apr; 35(4):207-13. PubMed ID: 10830072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the complement system.
    Marsh JE; Pratt JR; Sacks SH
    Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):557-62. PubMed ID: 10541217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.
    Khan MA; Hsu JL; Assiri AM; Broering DC
    Clin Exp Immunol; 2016 Feb; 183(2):175-86. PubMed ID: 26404106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Complement in Organ Transplantation.
    Grafals M; Thurman JM
    Front Immunol; 2019; 10():2380. PubMed ID: 31636644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C1-inhibitor and transplantation.
    Kirschfink M
    Immunobiology; 2002 Sep; 205(4-5):534-41. PubMed ID: 12396013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to avoid complement attack in baculovirus-mediated gene delivery.
    Kaikkonen MU; Ylä-Herttuala S; Airenne KJ
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S71-9. PubMed ID: 21784233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
    Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
    Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological manipulation of the complement system in human diseases.
    Asghar SS
    Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement components of the innate immune system in health and disease in the CNS.
    Gasque P; Dean YD; McGreal EP; VanBeek J; Morgan BP
    Immunopharmacology; 2000 Aug; 49(1-2):171-86. PubMed ID: 10904116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the complement system in rejection.
    Sacks SH; Chowdhury P; Zhou W
    Curr Opin Immunol; 2003 Oct; 15(5):487-92. PubMed ID: 14499254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of complement and perspectives for intervention in ischemia-reperfusion damage.
    Banz Y; Rieben R
    Ann Med; 2012 May; 44(3):205-17. PubMed ID: 21254897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells.
    Laumonier T; Walpen AJ; Maurus CF; Mohacsi PJ; Matozan KM; Korchagina EY; Bovin NV; Vanhove B; Seebach JD; Rieben R
    Transplantation; 2003 Sep; 76(5):838-43. PubMed ID: 14501864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multifaceted role of complement in kidney transplantation.
    Biglarnia AR; Huber-Lang M; Mohlin C; Ekdahl KN; Nilsson B
    Nat Rev Nephrol; 2018 Dec; 14(12):767-781. PubMed ID: 30367174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement therapeutics; history and current progress.
    Morgan BP; Harris CL
    Mol Immunol; 2003 Sep; 40(2-4):159-70. PubMed ID: 12914822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting complement at the time of transplantation.
    Sacks S; Karegli J; Farrar CA; Asgari E; Schwaeble W; Zhou W; Smith RA
    Adv Exp Med Biol; 2013; 735():247-55. PubMed ID: 23402032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complement inhibition: a new therapeutic modality?].
    Porcel JM
    Med Clin (Barc); 1995 Nov; 105(18):700-2. PubMed ID: 8538252
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of C-reactive protein and pentosan polysulphate on human complement activation.
    Klegeris A; Singh EA; McGeer PL
    Immunology; 2002 Jul; 106(3):381-8. PubMed ID: 12100726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.